同大類學(xué)科其它級(jí)別期刊:
中科院 1區(qū) 期刊 JCR Q1 期刊 中科院 2區(qū) 期刊 JCR Q2 期刊 中科院 3區(qū) 期刊 JCR Q3 期刊 中科院 4區(qū) 期刊 JCR Q4 期刊國(guó)際簡(jiǎn)稱:J BIOMED RES 參考譯名:生物醫(yī)學(xué)研究雜志
主要研究方向:MEDICINE, RESEARCH & EXPERIMENTAL 非預(yù)警期刊 審稿周期:
《生物醫(yī)學(xué)研究雜志》(Journal Of Biomedical Research)是一本由Nanjing Medical University出版的以MEDICINE, RESEARCH & EXPERIMENTAL為研究特色的國(guó)際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章,及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn),旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開(kāi)放期刊,近三年沒(méi)有被列入預(yù)警名單。
Journal of Biomedical Research is a comprehensive English academic journal in the field of medicine sponsored by Nanjing Medical University. Since its inception, it has always adhered to the purpose of promoting research in the biomedical field. It provides a high-quality academic exchange platform for scholars, doctors, and researchers both domestically and internationally. The magazine covers multiple branches of biomedical science, including basic medicine, clinical medicine, pharmacology, molecular biology, and more. It not only publishes original research papers, but also includes various types of papers such as review articles, case reports, technical reports, etc., to comprehensively reflect the latest developments in biomedical research.
It emphasizes the academic quality and innovation of papers, and all submissions undergo a strict peer review process. This magazine is not only an important showcase for the scientific research achievements of Nanjing Medical University, but also an important channel for biomedical researchers at home and abroad to learn about the latest research trends and academic achievements. Through continuous efforts and development, the academic influence of this journal in the biomedical field has gradually increased, becoming one of the widely recognized and cited academic journals by scholars at home and abroad.
CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||
4.6 | 0.551 | 0.581 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如,2022年的 CiteScore 計(jì)算方法為:2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量 注:文獻(xiàn)類型包括:文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) | 4區(qū) |
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | MULTIDISCIPLINARY SCIENCES 綜合性期刊 | 4區(qū) |
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q3 | 113 / 189 |
40.5% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q3 | 127 / 189 |
33.07% |
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
Frontiers In Public Health
中科院 3區(qū) JCR Q2
Bmc Psychiatry
中科院 2區(qū) JCR Q2
Bmc Neurology
中科院 3區(qū) JCR Q3
Bmc Public Health
中科院 2區(qū) JCR Q1
Bmc Womens Health
中科院 3區(qū) JCR Q2
Medcomm
中科院 3區(qū) JCR Q1